News

  • News

Alternative in animal testing: replacing them with virtual ones to sacrifice less

This September, a European project led by the Universitat Pompeu Fabra and where GRIB participates has been launched which aims to replace a quarter...

Read more

  • News

Mar Albà, Ferran sanz and Manuel Pastor in the ranking World’s Top 2% Scientist of Stanford’s University

The new edition of the ranking, which has just been published, includes 41 researchers who have worked at Hospital de Mar and the Research...

Read more

  • News

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

VICT3R is a new IHI-funded initiative aiming to revolutionize nonclinical safety testing by significantly reducing animal use in toxicology research....

Read more

  • News

Dr. Miguel Ángel Mayer participates in the report on Real World Data and Real World Evidence by the Council for International Organizations of Medical Sciences (CIOMS)

Dr. Miguel ángel Mayer contributed to the CIOMS report on Real World Data and Real World Evidence, guiding regulators on using this data. ...

Read more

  • News

Solving the puzzle of membrane receptors

The G-protein-coupled receptor-based drug development group, led by Jana Selent, creates molecular dynamics simulations that help find new drugs for nervous system diseases....

Read more

  • News

Prof. Joseph Schacherer as invited speaker at GRIB

Prof. Joseph Schacherer from the University of Strasbourg has done a seminar: "Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation"...

Read more

  • News

A study led by GRIB, has identified a group of microproteins exclusive to liver tumors that could be key to developing cancer vaccines

The research was led by the Evolutionary Genomics Research Group at the Hospital del Mar Research Institute, in collaboration with Cima University of Navarra...

Read more

  • News

Thesis defence of José Carlos Montañés: Discovery and evolutionary analysis of novel genes and translated ORFs

José Carlos will defend his thesis on July 11 at 10h, in 61.232 room of campus Mar Doctor Aiguader, 80.08003 Barcelona. ...

Read more

  • News

Dr. Jana Selent in new Avenues to Developing Personalized Treatments for Schizophrenia

An international study led by the Hospital del Mar Medical Research Institute (Dr. Jana Selent's group of GRIB) has demonstrated, for the first time,...

Read more